Under the direction of the head of Clinical Research, the Clinical Manager is responsible for the planning, management and execution of clinical trials from start-up to the completion of the trials. S/he will be responsible for daily clinical operations and ensure the close monitoring of all clinical activities, including project liaison with the CRO, vendors and business partners. The Clinical Manager is accountable to communicate with and support the clinical investigators.
We have two vacancies for this position. One we expect to fill November 2017 and one January 2018.
This opportunity is designed for someone who has experience in the Clinical aspects of Pharma and the Biotech industry, it is not designed for new graduates. This position could be remote, for someone with significant experience.
What you'll do
Responsibilities include, but are not limited to:
- Participate in the design, planning and implementation of clinical trials.
- Develop and ensure adherence to clinical trial timelines.
- Prepare, review and approve trial-related documents.
- Manage and oversee clinical activities from the start-up to the completion of the trials.
- Ensure proper communication of study progress to stakeholders.
- Identify, lead and manage CRO and other vendors.
- Responsible for the quality and compliance with protocols and study procedures and ensure audit readiness.
- Collaborate in the development of clinical SOP and guidelines.
- Communicate and support clinical investigators.
- Participate in the Site Initiation Visits and oversight of CRAs activities.
- Coordinate and manage the Investigational Product and clinical samples operations.
- Participate in the analysis of clinical trial results.
What you'll need
To be considered for this role, you must possess the following minimum qualifications:
- Masters degree in biological sciences
- A minimum of 3-5 years experience in clinical development with a minimum of 2 years in the management and coordination of clinical trials.
- Strong understanding and knowledge of GCP and ICH guidelines.
- Experience with CRO and vendor selection (RFP, Bid Defense) and management.
The ideal candidate will possess:
- A Ph.D. in biological sciences
- 5-10 years experience in clinical development with a minimum of 2 years in the management and coordination of clinical trials.
- Strong negotiation, communication and organization skills.
- Detail oriented and ability to prioritize.
- Show adaptability and empowerment.
- Capacity to work under pressure and tight timelines.
We're looking for
A little bit about us
Strong Science Needs Bright Minds
At Immunovaccine, we have high standards. And even higher aspirations.
Our drug candidates are helping us build on this promise. Our technology provides the tools that underscore this mission. And our people are the heart of our operation–the ultimate value-drivers upon which we, as a Company, rest.
We Work Better Together.
Curing diseases-especially the ones that continue to evade and outpace even the brightest minds in our industry-is hard work. Despite the intensity and ferocity of our business, the one thing we do not have to worry about is the morale and the spirit of our people. We work hard and we play hard. Our people enjoy our drive, our mission and the road less traveled here in Halifax. As it turns out, that does make all the difference.
We aim high with our mission, so we expect high performance from our people. Whether you are evaluating T cell responses, coordinating clinical operations with our partners, or working with our investor base, we depend on you to help realize the full value of our organization. In turn, we value you, and what you can bring to our Company. We support you in enjoying life fully while working towards your professional goals. Above all, we cultivate the camaraderie that is the hallmark of our corporate culture.
Happy Employees Produce Strong Results.
Talk to us about joining the Immunovaccine team.
Are you interested?
Work With Us
Our head office is on Summer Street in Halifax, Nova Scotia and we have an office in Quebec City, Quebec. This role could be a remote position should the candidate have sufficient experience. The normal work week is 35 hours, core hours being 9 am – 5 pm. This role will occasionally see early mornings, weekend work and/ or extended hours depending on the project underway at the time. You will spend most of your time in an office environment. You will sit or stand for most of your day. There will be some travel expected for this position, inclusive of professional development opportunities, we expect approximately 25%.
Salary and Benefits:
This will be a salaried position. Please indicate clearly on your application your desired salary for this role.
Compensation will be determined based upon skill set and experience of the selected candidate and benchmarking for the position. Immunovaccine offers paid vacation, health/ dental plan, employee assistance program, stock options, annual bonuses and cost of living increases to eligible employees.
If you feel that you are the best candidate for this position, please apply through the “Apply Now” button.
Please clearly indicate in your application how you meet the requirements for this role, and why you think you would be the best candidate for the role.
Applications will be considered upon receipt and until both positions have been filled. We anticipate one position to start November 2017, and the other in January 2018.
*We appreciate your application but only candidates selected for interviews will be contacted. We reserve the right to request interview candidates to complete skill/ behavior based assessments as part of the interview process.
** The successful candidate will be required to provide a Criminal Record Check before their start date.
Immunovaccine Inc. is a clinical-stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and infectious diseases. Immunovaccine develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented delivery agent that provides controlled and prolonged exposure of antigens and adjuvant to the immune system. Immunovaccine has advanced two T cell activation therapies for cancer through Phase 1 human clinical trials and is currently conducting a Phase 1b study with Incyte Corporation assessing lead cancer therapy, DPX-Survivac, as part of a triple combination therapy in ovarian cancer, as well as a Phase 2 study in recurrent lymphoma. The Company is also advancing an infectious disease pipeline, including innovative vaccines for respiratory syncytial virus (RSV), and currently has clinical projects ongoing to assess the potential of DepoVax™ to address malaria and the Zika virus. (Connect at www.imvaccine.com.)